The Column Group
About The Column Group
The Column Group is a venture capital firm dedicated to developing biotechnology companies.
Investment focus
Stages
Sectors
Portfolio (5 in our database)
Ribon TherapeuticsRibon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.Series C · $184M raisedA2 BiotherapeuticsA2 Biotherapeutics develops novel medicines for serious illness.Series B · $129M raisedHexagon BioHexagon Bio is a data-driven biotech developing targeted small molecule therapeutics.Series B · $116M raisedCasma TherapeuticsCasma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.Series B · $109M raisedAccent TherapeuticsAccent Therapeutics is a biopharmaceutical company.Series B · $103M raised